Products
PermeaDerm®
Products
PermeaDerm®
PermeaDerm is an FDA-cleared biosynthetic wound matrix for the treatment of partial-thickness wounds, surgical wounds, trauma wounds, donor sites, and the coverage of meshed autografts. Developed as a dual-layer skin substitute, PermeaDerm is comprised of an outer slitted 2D silicone epidermal analogue, which facilitates the diffusion of gas and exudate to/from the wound, and an inner 3D micro-support system with biocoating, which expedites adherence to the wound bed to support early patient mobilization.
Benefits of using PermeaDerm:



EASY TO USE
- Simple, one-time application
- Transparency allows at-a-glance wound assessment
- Quickly adheres to wound surface
- Flexible and adherent even on articulating joints
- Highly water resistant
CONVENIENT AND VERSATILE
- Suitable for wounds, donor sites, and over meshed autograft in all patients
- Expanded treatment utility with large sheets (up to 2,903 cm²) and glove options
- Less prone to stick to secondary dressings
- Usable without a secondary dressing after adherence
PROVEN EFFECTIVE
- Creates optimal healing environment, allowing epidermal migration
- Customizable moisture management (defined porosity through stretch)
- Provides bacterial barrier
- Protects wounds from trauma
Actively supports healing
As shown in a partial-thickness burn (during early phases of healing).
Primary adherence occurs within 5 hours due to clot formation within inner 3D micro-support system.1-4

Image credit: Geras Healthcare productions
Demonstrated clinical advantages. PermeaDerm creates an optimal environment to promote wound healing, typically within 7-14 days, after which it can be easily removed.1-4


Product information and sizing
Contact your AVITA Medical sales representative for unit and carton ordering details or to place an order.
Product code | Product Description | Typical Use |
---|---|---|
PermeaDerm C | ||
C2050500 | PermeaDerm 5" x 5" | Smaller wounds such as chronic wounds, surgical wounds, trauma wounds, draining wounds |
PermeaDerm B | ||
B1051000 | PermeaDerm 5" x 10" | Large wounds such as partial-thickness burns, trauma wounds, surgical wounds, donor sites, coverage over meshed autograft |
B2101500 | PermeaDerm 10" x 15" | |
B4153000 | PermeaDerm 15" x 30" | |
PermeaDerm Glove | ||
G1XS0000 | PermeaDerm Glove XS | Debrided partial-thickness hand burns |
G2S00000 | PermeaDerm Glove S | |
G3M00000 | PermeaDerm Glove M | |
G4L00000 | PermeaDerm Glove L | |
G5XL0000 | PermeaDerm Glove XL |
Resources that support you and your patients
frequently asked questions
- Woodroof A. et al, Eplasty. 2015. July e30. 2. FDA PermeaDerm 510(K) Premarket Notification.
- PermeaDerm Instructions for Use
- Significant economic advantage1
- Transparency allows for wound visualization and assessment2-3
- Tissue tracking is not required1
- PermeaDerm can be stored at room temperature for up to 5 years1
- Ease of wound and exudate management2-3
- No risk of disease transmission4
- Data on file. 2. Woodroof A, Phipps R, Woeller C, et al. Evolution of a biosynthetic temporary skin substitute: A preliminary study. Eplasty. 2015;Jul 20:15:e30. 3. FDA PermeaDerm 510(k) Premarket Notification 4. Voigt C, Williamson S, Kagan R, et al. The Skin Bank. Total Burn Care. 2018.
- Thoroughly debride/excise wound to remove all loose or necrotic tissue
- Remove PermeaDerm from the packet using aseptic technique
- Place 3D micro-support system side against debrided wound (“This Side Up” label should face away from the wound)
- Ensure application is wrinkle-free with slight tension (≤10% elongation; minimize elongation when using on face)
- Secure PermeaDerm via standard methods (e.g., staples, tape, sutures, skin glue)
- Place secondary dressing over PermeaDerm to absorb exudate and blood from the wound
- Remove outer and secondary dressings to check wound after initial 24-36 hours
- Leave PermeaDerm in place until healing occurs. PermeaDerm will peel away easily from healed skin
- Woodroof A. et al, Eplasty. 2015. July e30. 2. FDA PermeaDerm 510(K) Premarket Notification. 3. Greenwood, JE et al. Eplasty. 2011. Feb e10. 4. Greenwood, JE et al. Eplasty. 2009. June e25.
- PermeaDerm Instructions for Use
HCP Resources
REIMBURSEMENT SUPPORT SERVICES
AVITA Medical is available to assist you with your coding and reimbursement questions. See our coding guide for information about coding for the use of PermeaDerm:
For general coding, coverage, and reimbursement questions that do not involve specific cases or patient health information, please e-mail us at: hema@avitamedical.com
For more in-depth support with benefits verification, prior authorization, appeals, or case-specific inquiries, please contact AVITA Patient Access Services at:
- E-mail: support@avitapatientaccess.com
- Phone:1-833-674-1688
- Fax: 1-661-749-9430
References
1. Woodroof A, Phipps R, Woeller C, et al. Evolution of a biosynthetic temporary skin substitute: A preliminary study. Eplasty. 2015;Jul 20:15:e30.
2. FDA PermeaDerm 510(k) Premarket Notification.
3. Greenwood JE. A randomized, prospective study of the treatment of superficial partial-thickness burns: AWBAT-S versus Biobrane. Eplasty. 2011;Feb 24:11:e10.
4. Greenwood JE, Clausen J, Kavanagh S. Experience with Biobrane: uses and caveats for success. Eplasty. 2009;Jun 26:9:e25.
©2025 AVITA Medical. AVITA Medical® and the AVITA Medical logo are registered trademarks of AVITA Medical. PERMEADERM is a registered trademark owned by Stedical Scientific, Inc. All other trademarks are the properties of their respective owners.
Have questions?
Physicians: stay in touch
Sign Up to
Stay Connected